Table 1. Baseline charateristics of patients with liver cancer.
| Characteristics | Number of patients (%) |
|---|---|
| Age | |
| <55 | 117(31.62) |
| ≥55 | 253(68.38) |
| Gender | |
| FEMALE | 121(32.61) |
| MALE | 250(67.39) |
| Histological type | |
| Fibrolamellar Carcinoma | 3(0.81) |
| Hepatocellular Carcinoma | 361(97.3) |
| Hepatocholangiocarcinoma | 7(1.89) |
| Histologic grade | |
| G1 | 55(14.82) |
| G2 | 177(47.71) |
| G3 | 122(32.88) |
| G4 | 12(3.23) |
| NA | 5(1.35) |
| Stage | |
| I | 171(46.09) |
| II | 86(23.18) |
| III | 85(22.91) |
| IV | 5(1.35) |
| NA | 24(6.47) |
| T classification | |
| T1 | 181(48.79) |
| T2 | 94(25.34) |
| T3 | 80(21.56) |
| T4 | 13(3.5) |
| TX | 1(0.27) |
| NA | 2(0.54) |
| N classification | |
| N0 | 252(67.92) |
| N1 | 4(1.08) |
| NX | 114(30.73) |
| NA | 1(0.27) |
| M classification | |
| M0 | 266(71.7) |
| M1 | 4(1.08) |
| MX | 101(27.22) |
| Radiation therapy | |
| NO | 338(91.11) |
| YES | 8(2.16) |
| NA | 25(6.74) |
| Residual tumor | |
| R0 | 324(87.33) |
| R1 | 17(4.58) |
| R2 | 1(0.27) |
| RX | 22(5.93) |
| NA | 7(1.89) |
| Vital status | |
| DECEASED | 130(35.04) |
| LIVING | 241(64.96) |
| Relapse | |
| NO | 179(56.29) |
| YES | 139(43.71) |
| SNHG4 | |
| High | 75(20.22) |
| Low | 296(79.78) |